ClinicalTrials.gov record
Lab Study of MQX-503 in Treatment of Raynaud's
COMPLETED · NCT00253331
Trial record
NCT IDNCT00253331
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE2, PHASE3
Enrollment
36
Conditions
Raynaud Disease, Raynaud Disease Secondary to Scleroderma, Raynaud Secondary to Other Autoimmune Disease
Interventions
topical organogel with nitroglycerin
Locations
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States, University of Washington Medical College, Seattle, Washington, United States
Indexed topics
Last update
2007-05-29